MedPath
HSA Approval

UROCIT-K TABLET 1080 mg

SIN08734P

UROCIT-K TABLET 1080 mg

UROCIT-K TABLET 1080 mg

May 27, 1996

SG HEALTHCARE PTE. LTD.

SG HEALTHCARE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSG HEALTHCARE PTE. LTD.
Licence HolderSG HEALTHCARE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A12BA02

potassium citrate

Manufacturer Information

SG HEALTHCARE PTE. LTD.

MISSION PHARMACAL COMPANY

Active Ingredients

POTASSIUM CITRATE

1080 mg

Potassium citrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UROCIT-K TABLET 1080 mg - HSA Approval | MedPath